NU-7441 (KU-57788) is a potent and selective DNA-dependent protein kinase (DNA-PK) inhibitor. The IC50 values are 14, 1700, 5000, >100000 and >100000 nM for DNA-PK, mTOR, PI 3-K, ATM and ATR respectively.
More Information Supplier PageSRT3109 is a CXCR2 ligand for use in the treatment of chemokine mediated diseases and conditions.
More Information Supplier PageSRT3109 is a CXCR2 ligand for use in the treatment of chemokine mediated diseases and conditions.
More Information Supplier PageSRT3109 is a CXCR2 ligand for use in the treatment of chemokine mediated diseases and conditions.
More Information Supplier PageSRT3109 is a CXCR2 ligand for use in the treatment of chemokine mediated diseases and conditions.
More Information Supplier PageUR-144 is a potent synthetic cannabinoid (CB) which preferentially binds the peripheral CB2 receptor (Ki = 1.8 nM) over the central CB1 receptor (Ki = 150 nM).
More Information Supplier PageUR-144 is a potent synthetic cannabinoid (CB) which preferentially binds the peripheral CB2 receptor (Ki = 1.8 nM) over the central CB1 receptor (Ki = 150 nM).
More Information Supplier PageUR-144 is a potent synthetic cannabinoid (CB) which preferentially binds the peripheral CB2 receptor (Ki = 1.8 nM) over the central CB1 receptor (Ki = 150 nM).
More Information Supplier PageUR-144 is a potent synthetic cannabinoid (CB) which preferentially binds the peripheral CB2 receptor (Ki = 1.8 nM) over the central CB1 receptor (Ki = 150 nM).
More Information Supplier PagePKI-402 is a dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor.
More Information Supplier Page
